Sunday, February 07, 2021 2:56:03 PM
Since the NBC piece that mentioned IV trial results expected to be out this week (per the company), it wouldn't be a surprise that tomorrow morning top line results from the Phase III trial will be discussed.
While it might be good for the shareholders of BRPA if the merger were concluded before the results come out, there won't be enough time for the NeuroRX/BRPA merger to be finalized prior to results of the Phase III trial. In the SEC filings of BRPA, the S-4 still has blanks for dates of the vote on the merger etc.
Edit: Also, if this update were about the merger, certainly BRPA would be on the call as well. This call was billed as about NeuroRx business.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM